Create a checklist for fertility docs and clinics to ensure safe and effective integration of GLP-1s into fertility treatment regimens Checklist: baseline pregnancy test, informed consent covering side effects and intra-uterine/fetal data, metabolic and reproductive labs, schedule for combination therapy if applicable, monthly pregnancy testing schedule, discontinue GLP-1 two months prior to trying to conceive or stimulation pause weeks prior to surgeries under anesthesia, continued weight and hormone follow-up, contingency for potential side effects, patient education materials
For women: BMR = (10 x weight in kg) + (6.25 x height in cm) - (5 x age) - 161 For men: BMR = (10 x weight in kg) + (6.25 x height in cm) - (5 x age) + 5 For example, a 40-year-old woman who weighs 200 pounds (91 kg) and stands 5 feet 6 inches (168 cm) would calculate: (10 x 91) + (6.25 x 168) - (5 x 40) - 161 = 910 + 1,050 - 200 - 161 = 1,599 calories
Readers seeking the most current FDA position should consult FDA.gov directly
Certain medications may impact your candidacy for semaglutide
Por eso
NICE guidance (NG28) supports the use of GLP-1 receptor agonists in type 2 diabetes when metformin is insufficient, specifically for patients with a BMI 35 kg/m (or 30 kg/m with weight-related comorbidities), or for whom insulin would have significant occupational implications, or for whom weight loss would benefit obesity-related comorbidities
